We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WWW:NYSEWolverine World Wide, Inc. Analysis

Data as of 2026-06-29 - not real-time

$16.73

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

WWW is trading at $16.73, which sits below its 20‑day and 50‑day simple moving averages of 17.09 and 16.94, indicating short‑term pressure. The 200‑day SMA remains at 19.05, underscoring a longer‑term downtrend relative to current levels. Momentum is neutral with an RSI of 47, while the MACD histogram is negative and the signal line is bearish, suggesting limited upside in the immediate horizon. Volume has been stable, but price is hovering just above the identified support of 15.69 and well below resistance at 18.73. The stock’s beta of 1.42 and a 30‑day volatility of roughly 54% point to pronounced price swings. Despite these technical headwinds, the market sentiment index reads “Extreme Greed,” reflecting broader risk‑on appetite.
Fundamentally, WWW delivers an 11% revenue growth rate and a solid ROE of 29%, supporting its earnings outlook. The forward PE of 9.5 is well below the historical trailing PE of 13.6, indicating a value tilt. A discounted cash‑flow model places fair value at $17.11, implying roughly 30% upside from today’s price. The dividend yield of 2.33% with a payout ratio near 32% appears sustainable given strong operating cash flow. However, the company carries a high debt‑to‑equity ratio and has experienced a max drawdown of over 54%, adding leverage risk. Overall, the blend of attractive valuation, dividend income, and brand diversification makes the stock a compelling medium‑ to long‑term play.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support with bearish MACD
  • Neutral RSI and high short‑term volatility
  • Stable trading volume but limited upside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value indicates ~30% upside
  • Forward PE below 10 suggesting value appeal
  • Sustainable dividend yield with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong brand portfolio and revenue growth
  • Robust ROE and cash flow generation
  • Long‑term upside potential despite leverage

Key Metrics & Analysis

Financial Health

Revenue Growth11.00%
Profit Margin5.41%
P/E Ratio13.6
ROE29.24%
ROA6.22%
Debt/Equity181.32
P/B Ratio3.3
Op. Cash Flow$140.6M
Free Cash Flow$97.6M

Technical Analysis

TrendNeutral
RSI47.5
Support$15.69
Resistance$18.73
MA 20$17.09
MA 50$16.94
MA 200$19.05
MACDBearish
VolumeStable
Fear & Greed Index87.91

Valuation

Fair Value$17.11
Target Price$21.70
Upside/Downside29.71%
GradeUndervalued
TypeBlend
Dividend Yield2.33%

Risk Assessment

Beta1.42
Volatility53.86%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.